Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andreas W. Schreiber is active.

Publication


Featured researches published by Andreas W. Schreiber.


Cell | 2015

The RNA Binding Protein Quaking Regulates Formation of circRNAs

Simon J. Conn; Katherine A. Pillman; John Toubia; Vanessa Conn; Marika Salmanidis; Caroline A. Phillips; Suraya Roslan; Andreas W. Schreiber; Philip A. Gregory; Gregory J. Goodall

Circular RNAs (circRNAs), formed by non-sequential back-splicing of pre-mRNA transcripts, are a widespread form of non-coding RNA in animal cells. However, it is unclear whether the majority of circRNAs represent splicing by-products without function or are produced in a regulated manner to carry out specific cellular functions. We show that hundreds of circRNAs are regulated during human epithelial-mesenchymal transition (EMT) and find that the production of over one-third of abundant circRNAs is dynamically regulated by the alternative splicing factor, Quaking (QKI), which itself is regulated during EMT. Furthermore, by modulating QKI levels, we show the effect on circRNA abundance is dependent on intronic QKI binding motifs. Critically, the addition of QKI motifs is sufficient to induce de novo circRNA formation from transcripts that are normally linearly spliced. These findings demonstrate circRNAs are both purposefully synthesized and regulated by cell-type specific mechanisms, suggesting they play specific biological roles in EMT.


Functional & Integrative Genomics | 2006

An atlas of gene expression from seed to seed through barley development.

Arnis Druka; Gary J. Muehlbauer; Ilze Druka; Rico A. Caldo; Ute Baumann; Nils Rostoks; Andreas W. Schreiber; Roger P. Wise; Timothy J. Close; Andris Kleinhofs; Andreas Graner; Alan H. Schulman; Peter Langridge; Kazuhiro Sato; Patrick M. Hayes; James W. McNicol; David Marshall; Robbie Waugh

Assaying relative and absolute levels of gene expression in a diverse series of tissues is a central step in the process of characterizing gene function and a necessary component of almost all publications describing individual genes or gene family members. However, throughout the literature, such studies lack consistency in genotype, tissues analyzed, and growth conditions applied, and, as a result, the body of information that is currently assembled is fragmented and difficult to compare between different studies. The development of a comprehensive platform for assaying gene expression that is available to the entire research community provides a major opportunity to assess whole biological systems in a single experiment. It also integrates detailed knowledge and information on individual genes into a unified framework that provides both context and resource to explore their contributions in a broader biological system. We have established a data set that describes the expression of 21,439 barley genes in 15 tissues sampled throughout the development of the barley cv. Morex grown under highly controlled conditions. Rather than attempting to address a specific biological question, our experiment was designed to provide a reference gene expression data set for barley researchers; a gene expression atlas and a comparative data set for those investigating genes or regulatory networks in other plant species. In this paper we describe the tissues sampled and their transcriptomes, and provide summary information on genes that are either specifically expressed in certain tissues or show correlated expression patterns across all 15 tissue samples. Using specific examples and an online tutorial, we describe how the data set can be interrogated for patterns and levels of barley gene expression and how the resulting information can be used to generate and/or test specific biological hypotheses.


The Plant Cell | 2011

Cell-Specific Vacuolar Calcium Storage Mediated by CAX1 Regulates Apoplastic Calcium Concentration, Gas Exchange, and Plant Productivity in Arabidopsis

Simon J. Conn; Matthew Gilliham; Asmini Athman; Andreas W. Schreiber; Ute Baumann; Isabel Moller; Ninghui Cheng; Matthew A. Stancombe; Kendal D. Hirschi; Alex A. R. Webb; Rachel A. Burton; Brent N. Kaiser; Stephen D. Tyerman; Roger A. Leigh

Mineral elements are often preferentially stored in vacuoles of specific leaf cell types, but the mechanism and physiological role for this phenomenon is poorly understood. We use single-cell analysis to reveal the genetic basis underpinning mesophyll-specific calcium storage in Arabidopsis leaves and a variety of physiological assays to uncover its fundamental importance to plant productivity. The physiological role and mechanism of nutrient storage within vacuoles of specific cell types is poorly understood. Transcript profiles from Arabidopsis thaliana leaf cells differing in calcium concentration ([Ca], epidermis <10 mM versus mesophyll >60 mM) were compared using a microarray screen and single-cell quantitative PCR. Three tonoplast-localized Ca2+ transporters, CAX1 (Ca2+/H+-antiporter), ACA4, and ACA11 (Ca2+-ATPases), were identified as preferentially expressed in Ca-rich mesophyll. Analysis of respective loss-of-function mutants demonstrated that only a mutant that lacked expression of both CAX1 and CAX3, a gene ectopically expressed in leaves upon knockout of CAX1, had reduced mesophyll [Ca]. Reduced capacity for mesophyll Ca accumulation resulted in reduced cell wall extensibility, stomatal aperture, transpiration, CO2 assimilation, and leaf growth rate; increased transcript abundance of other Ca2+ transporter genes; altered expression of cell wall–modifying proteins, including members of the pectinmethylesterase, expansin, cellulose synthase, and polygalacturonase families; and higher pectin concentrations and thicker cell walls. We demonstrate that these phenotypes result from altered apoplastic free [Ca2+], which is threefold greater in cax1/cax3 than in wild-type plants. We establish CAX1 as a key regulator of apoplastic [Ca2+] through compartmentation into mesophyll vacuoles, a mechanism essential for optimal plant function and productivity.


Expert Opinion on Pharmacotherapy | 2009

Antiviral treatment of cytomegalovirus infection and resistant strains

Andreas W. Schreiber; Georg Härter; Axel Schubert; Donald Bunjes; Thomas Mertens; Detlef Michel

This review discusses the management of resistant cytomegalovirus and prevention strategies for fatal therapy failures. Five drugs, ganciclovir/valganciclovir, cidofovir, foscarnet and fomivirsen, have been approved so far for the treatment of human cytomegalovirus (HCMV) diseases. Except for fomivirsen, all of the approved drugs share the same target molecule, the viral DNA polymerase. The emergence of drug-resistant HCMV has also been reported for all of them. For optimal care of patients, the clinical virologist has to provide the most meaningful assays for monitoring of therapy and early detection of emerging drug-resistant HCMV. Additionally, a quantitative drug monitoring would be helpful. New antiviral agents are urgently needed with less adverse effects, good oral bioavailability and possibly novel targets or mechanisms of action to avoid cross-resistance and to improve the ability to suppress the selection of resistant virus strains by combination therapy. Compounds like maribavir, leflunomide and artesunate, which exhibit anti-HCMV activity in vitro and in patients need to be evaluated in clinical studies. Besides these, new therapy approaches like immunotherapy or new diagnostic techniques like pyrosequencing have to be considered in the future.


Blood | 2016

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies

Maya Lewinsohn; Anna L. Brown; Luke M. Weinel; Connie Phung; George Rafidi; Ming K. Lee; Andreas W. Schreiber; Jinghua Feng; Milena Babic; Chan Eng Chong; Young Kyung Lee; Agnes S. M. Yong; Graeme Suthers; Nicola Poplawski; Meryl Altree; Kerry Phillips; Louise Jaensch; Miriam Fine; Richard J. D'Andrea; Ian D. Lewis; Bruno C. Medeiros; Daniel A. Pollyea; Mary Claire King; Tom Walsh; Siobán B. Keel; Akiko Shimamura; Lucy A. Godley; Christopher N. Hahn; Jane E. Churpek; Hamish S. Scott

Recently our group and others have identified DDX41 mutations both as germ line and acquired somatic mutations in families with multiple cases of late onset myelodysplastic syndrome (MDS) and/or acute myeloid leukemia (AML), suggesting that DDX41 acts as a tumor suppressor. To determine whether novel DDX41 mutations could be identified in families with additional types of hematologic malignancies, our group screened two cohorts of families with a diverse range of hematologic malignancy subtypes. Among 289 families, we identified nine (3%) with DDX41 mutations. As previously observed, MDS and AML were the most common malignancies, often of the erythroblastic subtype, and 1 family displayed early-onset follicular lymphoma. Five novel mutations were identified, including missense mutations within important functional domains and start-loss and splicing mutations predicted to result in truncated proteins. We also show that most asymptomatic mutation carriers have normal blood counts until malignancy develops. This study expands both the mutation and phenotypic spectra observed in families with germ line DDX41 mutations. With an increasing number of both inherited and acquired mutations in this gene being identified, further study of how DDX41 disruption leads to hematologic malignancies is critical.


Bioinformatics | 2013

A comparative analysis of algorithms for somatic SNV detection in cancer

Nicola Roberts; R. Daniel Kortschak; Wendy T. Parker; Andreas W. Schreiber; Susan Branford; Hamish S. Scott; Garique Glonek; David L. Adelson

Motivation: With the advent of relatively affordable high-throughput technologies, DNA sequencing of cancers is now common practice in cancer research projects and will be increasingly used in clinical practice to inform diagnosis and treatment. Somatic (cancer-only) single nucleotide variants (SNVs) are the simplest class of mutation, yet their identification in DNA sequencing data is confounded by germline polymorphisms, tumour heterogeneity and sequencing and analysis errors. Four recently published algorithms for the detection of somatic SNV sites in matched cancer–normal sequencing datasets are VarScan, SomaticSniper, JointSNVMix and Strelka. In this analysis, we apply these four SNV calling algorithms to cancer–normal Illumina exome sequencing of a chronic myeloid leukaemia (CML) patient. The candidate SNV sites returned by each algorithm are filtered to remove likely false positives, then characterized and compared to investigate the strengths and weaknesses of each SNV calling algorithm. Results: Comparing the candidate SNV sets returned by VarScan, SomaticSniper, JointSNVMix2 and Strelka revealed substantial differences with respect to the number and character of sites returned; the somatic probability scores assigned to the same sites; their susceptibility to various sources of noise; and their sensitivities to low-allelic-fraction candidates. Availability: Data accession number SRA081939, code at http://code.google.com/p/snv-caller-review/ Contact: [email protected] Supplementary information: Supplementary data are available at Bioinformatics online.


Annals of Neurology | 2016

Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy.

Michael G. Ricos; Bree L. Hodgson; Tommaso Pippucci; Akzam Saidin; Yeh Sze Ong; Sarah E. Heron; Laura Licchetta; Francesca Bisulli; Marta A. Bayly; James N. Hughes; Sara Baldassari; Flavia Palombo; Margherita Santucci; Stefano Meletti; Samuel F. Berkovic; Guido Rubboli; Paul Q. Thomas; Ingrid E. Scheffer; Paolo Tinuper; Joel Geoghegan; Andreas W. Schreiber; Leanne M. Dibbens

Focal epilepsies are the most common form observed and have not generally been considered to be genetic in origin. Recently, we identified mutations in DEPDC5 as a cause of familial focal epilepsy. In this study, we investigated whether mutations in the mammalian target of rapamycin (mTOR) regulators, NPRL2 and NPRL3, also contribute to cases of focal epilepsy.


The Journal of Clinical Endocrinology and Metabolism | 2014

ARMC5 Mutations Are Common in Familial Bilateral Macronodular Adrenal Hyperplasia

Lucia Gagliardi; Andreas W. Schreiber; Christopher N. Hahn; Jinghua Feng; Treena Cranston; Hannah Boon; Cheri Hotu; Bergithe E. Oftedal; Richard Cutfield; David L. Adelson; Wilton J. Braund; Richard D. Gordon; D. Aled Rees; Ashley B. Grossman; David J. Torpy; Hamish S. Scott

CONTEXT Bilateral macronodular adrenal hyperplasia (BMAH) is a rare form of adrenal Cushings syndrome. Familial cases have been reported, but at the time we conducted this study, the genetic basis of BMAH was unknown. Recently, germline variants of armadillo repeat containing 5 (ARMC5) in patients with isolated BMAH and somatic, second-hit mutations in tumor nodules, were identified. OBJECTIVE Our objective was to identify the genetic basis of familial BMAH. DESIGN We performed whole exome capture and sequencing of 2 affected individuals from each of 4 BMAH families (BMAH-01, BMAH-02, BMAH-03, and BMAH-05). Based on clinical evaluation, there were 7, 3, 3, and 4 affected individuals in these families, respectively. Sanger sequencing of ARMC5 was performed in 1 other BMAH kindred, BMAH-06. RESULTS Exome sequencing identified novel variants Chr16:g.31477540, c.2139delT, p.(Thr715Leufs*1) (BMAH-02) and Chr16:g.31473811, c.943C→T, p.(Arg315Trp) (BMAH-03) in ARMC5 (GRch37/hg19), validated by Sanger sequencing. BMAH-01 had a recently reported mutation Chr16:g.31476121, c.1777C→T, p.(Arg593Trp). Sanger sequencing of ARMC5 in BMAH-06 identified a previously reported mutation, Chr16:g. 31473688; c.799C→T, p.(Arg267*). The genetic basis of BMAH in BMAH-05 was not identified. CONCLUSIONS Our studies have detected ARMC5 mutations in 4 of 5 BMAH families tested, confirming that these mutations are a frequent cause of BMAH. Two of the 4 families had novel mutations, indicating allelic heterogeneity. Preclinical evaluation did not predict mutation status. The ARMC5-negative family had unusual prominent hyperaldosteronism. Further studies are needed to determine the penetrance of BMAH in ARMC5 mutation-positive relatives of affected patients, the practical utility of genetic screening and genotype-phenotype correlations.


Physical Review D | 1994

Deep inelastic scattering from off-shell nucleons

W. Melnitchouk; Andreas W. Schreiber; A. W. Thomas

We derive the general structure of the hadronic tensor required to describe deep-inelastic scattering from an off-shell nucleon within a covariant formalism. Of the large number of possible off-shell structure functions we find that only three contribute in the Bjorken limit. In our approach the usual ambiguities encountered when discussing problems related to off-shellness in deep-inelastic scattering are not present. The formulation therefore provides a clear framework within which one can discuss the various approximations and assumptions which have been used in earlier work. As examples, we investigate scattering from the deuteron, nuclear matter and dressed nucleons. The results of the full calculation are compared with those where various aspects of the off-shell structure are neglected, as well as with those of the convolution model.


Annals of Neurology | 2015

Mutations in the mTOR pathway regulators NPRL2 and NPRL3 cause focal epilepsy

Michael G. Ricos; Bree L. Hodgson; Tommaso Pippucci; Akzam Saidin; Yeh Sze Ong; Sarah E. Heron; Laura Licchetta; Francesca Bisulli; Marta A. Bayly; James N. Hughes; Sara Baldassari; Flavia Palombo; Margherita Santucci; Stefano Meletti; Samuel F. Berkovic; Guido Rubboli; Paul Q. Thomas; Ingrid E. Scheffer; Paolo Tinuper; Joel Geoghegan; Andreas W. Schreiber; Leanne M. Dibbens

Focal epilepsies are the most common form observed and have not generally been considered to be genetic in origin. Recently, we identified mutations in DEPDC5 as a cause of familial focal epilepsy. In this study, we investigated whether mutations in the mammalian target of rapamycin (mTOR) regulators, NPRL2 and NPRL3, also contribute to cases of focal epilepsy.

Collaboration


Dive into the Andreas W. Schreiber's collaboration.

Top Co-Authors

Avatar

Hamish S. Scott

Institute of Medical and Veterinary Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jinghua Feng

Institute of Medical and Veterinary Science

View shared research outputs
Top Co-Authors

Avatar

Susan Branford

Institute of Medical and Veterinary Science

View shared research outputs
Top Co-Authors

Avatar

Wendy T. Parker

Institute of Medical and Veterinary Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Wang

Institute of Medical and Veterinary Science

View shared research outputs
Top Co-Authors

Avatar

David T. Yeung

Institute of Medical and Veterinary Science

View shared research outputs
Top Co-Authors

Avatar

Anna L. Brown

University of South Australia

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge